SCHEMBL4787346

SCHEMBL4787346

COc1cc(CNC(=O)C=Cc2ccc3[nH]cc(CCN(C)C)c3c2)cc(OC)c1OC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.78
ALDH1A1 P00352 2/20 0.78
LMNA P02545 2/20 0.78
CYP1A2 P05177 2/20 0.78
HTR1A P08908 2/20 0.78
HTR1D P28221 2/20 0.78
HTR1B P28222 2/20 0.78
TP53 P04637 1/20 0.78
CYP3A4 P08684 1/20 0.78
TSHR P16473 1/20 0.78
PMP22 Q01453 1/20 0.78
NPSR1 Q6W5P4 1/20 0.78
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
ACHE P22303 3/20 0.51
BCHE P06276 1/20 0.51
HDAC3 O15379 4/20 0.50
HDAC6 Q9UBN7 4/20 0.50
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787341 1.00 KDM4E (0.78) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4784837 0.88 HTR1D (1.00) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL30058389 0.88 HTR1D (1.00) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4784832 0.88 HTR1D (1.00) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4787880 0.87 HTR1D (0.79) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4787875 0.87 HTR1D (0.79) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4788261 0.85 HTR1D (0.79) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4788256 0.85 HTR1D (0.79) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL18622645 0.84 HTR1A (0.81) KDM4EALDH1A1LMNACYP1A2HTR1A
SCHEMBL4784970 0.84 HTR1A (0.80) KDM4EALDH1A1LMNACYP1A2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008118445-A9 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORP (US) 2008-12-04 WO claimed
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION 2008-10-09 US claimed
WO-2008118445-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION (US) 2008-10-02 WO claimed
WO-2008118445-A9 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORP (US) 2008-12-04 WO disclosed
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION 2008-10-09 US disclosed
WO-2008118445-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION (US) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS GLO1, ESD, GLB1 KDM4E 1027/4885ALDH1A1 349/4885LMNA 2711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.